Abstract
Although the benzodiazepines have been extensively investigated since their discovery about 20 years ago1, only recently have antagonists of the classical actions of benzodiazepines been described2. We have now discovered a class of benzodiazepines which have lost all affinity for benzodiazepine binding sites but which have moderate to high affinity for opiate receptors. Depending on the substituents introduced, it is possible to obtain compounds with selective actions on μ, δ and κ subpopulations of opiate receptors. The compounds are effective analgesics in various animal models of pain, exhibit an opioid activity spectrum in various test systems, and show none of the typical effects of minor tranquillizers. Here we report that 1-methyl-2(3-thienylcarbonyl)-aminomethyl-5-(2-fluorophenyl)-H-2,3-dihydro-l,4-benzodiazepine (KC5103; tifluadom), acts selectively on opiate κ-receptors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sternbach, L. H. J. med. Chem. 22, 1–7 (1979); Arzneimittel-Forsch. 30, 851–916 1980).
Hunkler, W. et al. Nature 290, 514–516 (1981).
Liepmann, H., Milkowski, W. & Zeugner, H. Eur. J. med. Chem. 11, 501 (1976).
Li, P.-L. in Proc. Workshop on Cell Surface Receptors—Basic and Clinical Aspects Cambridge, 1982 (Horwood, London, in the press).
Milkowski, W. et al. Chem. Abstr. 86, 89913W (1977).
Laakman, G. & Hippius, H. Adv. Biosci. 31, 125–134 (1981).
Zeugner, H. et al. Chem. Abstr. 95, 169234b (1981).
Garattini, S., Mussini, E. & Randall, L. O. in The Benzodiazepines 36ff (Raven, New York, 1973).
Pircio, A. W., Fedele, C. T. & Bierwagen, M. E. Eur. J. Pharmac. 31, 207–215 (1975).
Kosterlitz, H. W., Paterson, S. J. & Robson, L. E. Br. J. Pharmac. 73, 939–949 (1981).
Römer, D. et al. Life Sci. 27, 971–978 (1980).
Oka, T. et al. Eur. J. Pharmac. 73, 235–236 (1981).
Römer, D., Hill, R. C. & Maurer, R. in Proc. 3rd World Cong. on Pain, Edinburgh, 1981 (Raven, New York, in the press).
D'Amour, D. E. & Smith, D. L. J. Pharmac. exp. Theor. 72, 74–78 (1941).
Lord, J. A. H., Waterfield, A. A., Hughes, J. & Kosterlitz, H. W. Nature 267, 495–499 (1977).
Pert, C. B. & Snyder, S. H. Proc. natn. Acad. Sci. U.S.A. 70, 2243–2247 (1973).
Kosterlitz, H. W. & Watt, A. J. Br. J. Pharmac. 33, 266–276 (1968).
Henderson, G., Hughes, J. & Kosterlitz, H. W. Br. J. Pharmac. 46, 764–766 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Römer, D., Büscher, H., Hill, R. et al. An opioid benzodiazepine. Nature 298, 759–760 (1982). https://doi.org/10.1038/298759a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/298759a0
This article is cited by
-
Prospects of a Search for Kappa-Opioid Receptor Agonists with Analgesic Activity (Review)
Pharmaceutical Chemistry Journal (2018)
-
Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze
Psychopharmacology (1995)
-
Characterization of diazepam-insensitive [3H]Ro 15-4513 binding in rodent brain and cultured cerebellar neuronal cells
Neurochemical Research (1994)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
